Thermostable bivalent & trivalent filovirus vaccines from insect cells: potency demonstrated after 3 months and 2 years
Authors:
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases (1R01AI132323)
- NIH National Institute of General Medical Sciences (P30GM103516)
- University of Hawai'i
- National Institutes of Health
This publication has 23 references indexed in Scilit:
- Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-dryingInternational Journal of Pharmaceutics, 2022
- Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in miceVaccine: X, 2021
- Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvantVaccine, 2021
- Stability of lyophilized and spray dried vaccine formulationsAdvanced Drug Delivery Reviews, 2021
- Thin-Film Freeze-Drying Is a Viable Method to Convert Vaccines Containing Aluminum Salts from Liquid to Dry Powder2020
- Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challengeVaccine, 2019
- Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxideEuropean Journal of Pharmaceutics and Biopharmaceutics, 2019
- Physical and chemical changes in Alhydrogel™ damaged by freezingVaccine, 2018
- Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in miceVaccine, 2017
- Ebola and Marburg haemorrhagic feverJournal of Clinical Virology, 2015